Emerging Therapies for Managing Complement 3 Glomerulopathy

powernephron
Published on Dec 13, 2022
Chair, Carla M. Nester, MD, MSA, FASN, discusses complement 3 glomerulopathy in this CME activity titled â€œHope Is on the Horizon: The Clinical Potential of Emerging Disease-Modifying Therapies for Managing Complement 3 Glomerulopathy.â€ For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JCU865. CME credit will be available until February 23, 2023.